Downstream proteins, such as AP-1 (oncogene c-Jun/c-Fos) are activated via Rac/PAK/MEK/ERK, and target of rapamycin is inhibited, eventually contributing to the proliferation of tumor cells. This evidence concerns the gene FOS and neoplasm.